UBS put out a new valuation today siting a solid Q3 result. Also discussed the risk with the current CBI Investigation.
UBS put the 12 month valuation at $5.30 (last close $3.48) a nice outlook!
But then goes on it divvi up the outcomes of the investigation: "We then include a $0.91 discount for UBSe blended range of investigation outcomes". This, if EML gets off with a wrist smack, whatever, then the UBS valuation is $6.21 , A 71% increase on todays close.
Thats quite good enough for me to hang on at the risk of the investigation. :)
Mark